DSM Venturing, the corporate venturing unit of Royal DSM N.V., announces that it has made an equity investment in The Compliers Group International B.V. (TCG). The Netherlands-based company focuses on the development of smart pharmaceutical packaging solutions that contain microchips which enable the monitoring of a patient’s therapy compliance.
TCG’s smart packaging solutions can be applied in any existing standard medication blister and will record when a pill has been removed from the blister. This information can be read out wirelessly (e.g. with a mobile phone) and made available to caregivers and patients in day-to-day medication therapy or to pharmaceutical companies or research organizations in clinical studies.
The system will help both patients and volunteers taking part in clinical studies to take their pills at the right time. Caregivers and pharmaceutical companies will be able to better diagnose or judge the effectiveness of medication. This can help to substantially reduce healthcare costs.
First proof of concept of TCG’s “Objective therapy Compliance Measurement” (OtCM®) technology has been obtained. TCG also applies its technology in projects with Ministries of Health, health insurers and others, such as research organizations.
Tony de Vrught, Vice President DSM Specialty Packaging says: “ Intelligent packaging systems aimed at improving patient adherence could substantially contribute to decreasing overall healthcare costs in the future as they reduce the need for more costly interventions. I see this as a logical step forward in combining our knowledge of Life Sciences and Materials Sciences opening up interesting perspectives in innovative packaging applications. I look forward to working with TCG to develop innovative solutions for this market.”
Jos Geboers and Willem Kort, Founders and Managing Directors of TCG: “ This partnership with DSM will help us to refine our product and market development path. Our combined capabilities will accelerate the global implementation of our products, technologies and services as DSM has unique knowledge in both Life Sciences and Materials Sciences.”